Literature DB >> 3084254

Purification and structural characterization of intact and fragmented nidogen obtained from a tumor basement membrane.

M Paulsson, R Deutzmann, M Dziadek, H Nowack, R Timpl, S Weber, J Engel.   

Abstract

Extraction of a basement-membrane-producing mouse tumor with 6 M guanidine/HCl in the presence of protease inhibitors allowed the purification of the genuine form of the matrix protein nidogen (Mr = 150,000) and, in addition, two defined fragments (Mr = 130,000 and 100,000). Smaller fragments (Mr = 80,000 and 40,000) were obtained under conditions with less stringent control of endogenous proteolysis. Intact nidogen and the larger fragments were similar in amino acid and carbohydrate (about 5%) composition, the presence of a single polypeptide chain, conformational features as revealed by CD spectroscopy and all shared major epitopes located on the Mr = 80,000 fragment. Additional epitopes were found on intact nidogen and the Mr = 130,000 fragment. Nidogen and the various fragments possess different N-terminal amino acid sequences indicating a stepwise degradation from the N-terminal end of the molecule. Electron microscopical and hydrodynamic studies of the Mr = 80,000 fragment demonstrated a structure consisting of a globular head connected to a thin tail. Intact nidogen appears to contain a somewhat larger globule but the same tail, which is terminated at its opposite end by a second, smaller globular structure. The data suggest a multidomain structure for nidogen containing sites highly susceptible to proteolytic cleavage.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3084254     DOI: 10.1111/j.1432-1033.1986.tb09605.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  15 in total

Review 1.  Autoimmunity and glomerulonephritis.

Authors:  R Saxena; C Johansson; P Bygren; J Wieslander
Journal:  Postgrad Med J       Date:  1992-04       Impact factor: 2.401

Review 2.  Basement membrane heterogeneity.

Authors:  F T Bosman; J Cleutjens; C Beek; M Havenith
Journal:  Histochem J       Date:  1989-11

3.  Cranin: a laminin-binding protein of cell membranes.

Authors:  N R Smalheiser; N B Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

Review 4.  Antigens of the human glomerular basement membrane.

Authors:  L S Fouser; A F Michael
Journal:  Springer Semin Immunopathol       Date:  1987

Review 5.  Role of laminin-nidogen complexes in basement membrane formation during embryonic development.

Authors:  M Dziadek
Journal:  Experientia       Date:  1995-09-29

6.  Human nidogen: cDNA cloning, cellular expression, and mapping of the gene to chromosome Iq43.

Authors:  D R Olsen; T Nagayoshi; M Fazio; M G Mattei; E Passage; D Weil; R Timpl; M L Chu; J Uitto
Journal:  Am J Hum Genet       Date:  1989-06       Impact factor: 11.025

7.  Structure and distribution of N-linked oligosaccharide chains on various domains of mouse tumour laminin.

Authors:  S Fujiwara; H Shinkai; R Deutzmann; M Paulsson; R Timpl
Journal:  Biochem J       Date:  1988-06-01       Impact factor: 3.857

8.  Gene structure and functional analysis of the mouse nidogen-2 gene: nidogen-2 is not essential for basement membrane formation in mice.

Authors:  Jürgen Schymeinsky; Sabine Nedbal; Nicolai Miosge; Ernst Pöschl; Cherie Rao; David R Beier; William C Skarnes; Rupert Timpl; Bernhard L Bader
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

9.  Recombinant nidogen consists of three globular domains and mediates binding of laminin to collagen type IV.

Authors:  J W Fox; U Mayer; R Nischt; M Aumailley; D Reinhardt; H Wiedemann; K Mann; R Timpl; T Krieg; J Engel
Journal:  EMBO J       Date:  1991-11       Impact factor: 11.598

10.  Amino acid sequence of mouse nidogen, a multidomain basement membrane protein with binding activity for laminin, collagen IV and cells.

Authors:  K Mann; R Deutzmann; M Aumailley; R Timpl; L Raimondi; Y Yamada; T C Pan; D Conway; M L Chu
Journal:  EMBO J       Date:  1989-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.